Illumina Expands IP Offer to Help Save PacBio Deal as Oxford Nanopore Cries Foul

Nov 20, 2019

|

NEW YORK – Illumina has expanded its offer to open sequencing-related intellectual property held by itself and Pacific Biosciences to competitors in order to persuade the UK's Competition and Markets Authority to allow its planned $1.2 billion acquisition of PacBio to go forward.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Shift to New Variant Work

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

Victim Identified with Genetic Genealogy

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Featured White Papers

In-depth Quantification of Cell and Gene Therapy DNA Integrations Enabled with Single-cell Sequencing

Deep Understanding of Cell and Gene Therapy Genome Editing Protocols Enabled With Single-cell Sequencing

Illuminating the Role of the Adaptive Immune Response in Neurodegeneration

Transcriptional Profiling of 1.3 Million Brain Cells with the Chromium Single Cell Gene Expression Solution

Jan

28

Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb

18

Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.

Menu

Illumina Expands IP Offer to Help Save PacBio Deal as Oxford Nanopore Cries Foul

To read the full story....

Breaking News

Bioron to Distribute GenapSys Sequencing Technology in Germany

Mobilion, Protein Metrics Partner on Ion Mobility Mass Spec Data Analysis Tools

Genomind Receives Medicare Coverage for Pharmacogenetics Test

Thermo Fisher Scientific, SPT Labtech to Comarket Sequencing Library Prep Products

BC Platforms, Finnish Researchers, Japan's Riken Partner on COVID-19 Risk Assessment

NRGene Completes $30.6M IPO

The Scan

Shift to New Variant Work

Victim Identified with Genetic Genealogy

PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling

Should Also Work

Featured White Papers

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

What's Popular?

Hong Kong Team Develops Method to Improve PacBio Direct Cytosine Methylation Detection

Thermo Fisher Scientific, SPT Labtech to Comarket Sequencing Library Prep Products

Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

NRGene Completes $30.6M IPO

Bioron to Distribute GenapSys Sequencing Technology in Germany

Sponsorships